Our partner, Dr. Vijay Yajnik, Vice President and Head of Gastroenterology, U.S. Medical Affairs at Takeda, understands firsthand the complexities of conducting GI trials and shares our vision of using technology to enable effective and efficient clinical trials that provide deeper insights into disease activity. Learn more about our scientific collaborations with leaders in the GI scientific community in our recent press release: https://lnkd.in/eSfgBJ5a
Iterative Health
Medical Equipment Manufacturing
Cambridge, Massachusetts 18,083 followers
Computer vision augmented decisions for gastroenterology
About us
Iterative Health is a healthcare technology & services company on a mission to provide timely access to a higher standard of gastroenterology care. With deep expertise in artificial intelligence and clinical research, we’re empowering healthcare professionals to provide consistently high-quality colorectal cancer screenings and supporting clinical research teams and study sponsors to expand and accelerate patient access to novel therapeutics. The company is based in Cambridge, Massachusetts, with offices across the United States. Recruitment Impersonation Notice: It has come to our attention that one or more individuals have recently been falsely representing themself to be an Iterative Health recruiter and/or hiring manager in email and/or LinkedIn communications with job candidates. We have notified authorities of this conduct. Please note that genuine messages from our team only come from official Iterative Health emails (@iterativescopes.com or @iterative.health) or via one of our recruiters, identified clearly as such, on LinkedIn. If you receive any suspicious messages or would like to verify that your communication with our team is authentic, please do not hesitate to reach out to us at recruiting@iterative.health. Notifying our team will in no way impact any potential hiring decisions made by Iterative Health.
- Website
-
https://iterative.health/
External link for Iterative Health
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Computer Aided Diagnostics and Machine Learning
Locations
-
Primary
14 Arrow St
Cambridge, Massachusetts 02138, US
Employees at Iterative Health
Updates
-
We are proud to share that our abstract, “Head-to-Head Evaluation of Two Machine Learning Algorithms for Predicting Endoscopic Mayo Score in Ulcerative Colitis,” has been honored with the Presidential Poster Award at #ACG2024, recognizing high-quality, novel, and groundbreaking research. Learn more about all five abstracts presented at ACG, co-authored with leading academic researchers and life sciences partners. These publications showcase the opportunity for advanced machine learning (ML) algorithms to address shortcomings in the current approach to endoscopic assessment of inflammatory bowel disease (IBD) in clinical trials and routine care. Explore each abstract: https://lnkd.in/eE4wBEZk https://lnkd.in/eYsVCEr6 https://lnkd.in/ena4az4y https://lnkd.in/eq2t69NA https://lnkd.in/eMB4Q2-p
-
We are honored to partner with Dr. David Rubin, Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine, as a presenting author at #ACG2024. Our work showcases our shared passion for evolving traditional endoscopic assessments to advance efficacy measurements in GI clinical trials and the opportunity for machine learning to impact drug development processes and patient outcomes. Read the full press release here:https://lnkd.in/eSfgBJ5a
-
We’re excited to announce that Iterative Health will be presenting five abstracts at #ACG2024 in collaboration with leading academic researchers and life science partners. The studies highlight the opportunity for advanced machine learning algorithms to address gaps in endoscopic assessments, evolve traditional endpoints, and shift the paradigm in evidence generation for GI diseases. Dr. Shrujal Baxi, MPH, Chief Medical Officer at Iterative Health, stated, “We are focused on evolving traditional endpoints, such as endoscopic scoring, to deliver new, actionable insights. Collaborating with our industry partners to produce and present new data is a key step in our long-term strategy to shift the paradigm in evidence generation for GI diseases.” Thank you to all our partners in the GI scientific community for our ongoing collaborations to lay the foundation for future innovation in drug development and endpoint assessments in clinical trials and routine care. Read the full press release here: https://lnkd.in/eSfgBJ5a
-
Our team is embracing the cozy vibes of autumn with a special Fall Challenge! Each week, we’re getting creative and festive with activities that celebrate the season. From showing off our favorite fall-inspired décor to visiting pumpkin patches and baking fall treats, everyone is bringing their best autumn spirit! #FallChallenge #TeamFun #AutumnVibes
-
Meet with our Life Sciences team members Mark R. Molenda, RPh, and Blake Thomas at #uegweek in Vienna this weekend, Oct 12-15! Let’s chat about how we’re advancing GI & Hepatology clinical trials with our elite, global site network in collaboration with Pharma, Biotech, and CROs. #ClinicalTrials #Hepatology #Gastroenterology #myUEGcommunity
-
See the difference an in-house team of machine learning experts and data scientists can make! With SKOUT 2, our real-time #polypdetection technology, we are able to rapidly bring clinically meaningful enhancements in AI polyp detection technology to life. In just six months, we supercharged SKOUT with 2.5x more data from 10x more facilities – doubling our detection speed and increasing sensitivity by over 40%. Want to learn more? Request a demo to see SKOUT 2.0 in action: https://lnkd.in/ehUY4irQ #AIforGI #gastroenterology
-
Meet Brice Schreter, Manager of Life Sciences, at Society for Clinical Research Sites (SCRS)‘s Site Solutions Summit in Hollywood, FL this weekend! Don’t miss the opportunity to connect and discover how Iterative Health is driving strategic partnerships with Pharma, Biotech, and CROs to accelerate the clinical trials needed to bring new #gi & #Hepatology therapies to market leveraging our leading clinical research site network. #ClinicalTrials #Gastroenterology
-
Tomorrow marks the start of the Texas Society for Gastroenterology and Endoscopy's Annual Meeting! Be sure to stop by booth#24 to meet Neal Smith and Nick Coppola for a demo of SKOUT, our real-time AI technology for polyp detection.
-
Today is #CeliacAwarenessDay, a time to raise awareness about #celiacdisease. This autoimmune disorder damages the small intestine when gluten is consumed and occurs in about 1% of people in most populations. Early diagnosis and effective management are vital to minimizing long-term health issues. At Iterative Health, we work closely with sponsors and clinical research sites to accelerate access to new treatments for gastrointestinal diseases, including those aimed at improving the lives of Celiac patients. Our team is dedicated to advancing clinical research that offers hope for more personalized and effective therapies.#Clinicaltrials #Gastroenterology